Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Megakaryocyte Reprogramming in Breast Cancer

Harvey G. Roweth, BSc, PhD, Michael Malloy, BS, Gregory Goreczny, BS, PhD, Kelly E. Johnson, BS, PhD, Sandra S. McAllister, PhD, Joseph E. Italiano, Jr., BS, PhD, Elisabeth Battinelli, MD PhD

Blood (2019) 134 (Supplement_1): 12.

https://doi.org/10.1182/blood-2019-124894

Published: 2019

Journal Articles

Extramedullary Hematopoiesis in the Absence of Myeloproliferative Neoplasm: Mayo Clinic Case Series of 309 Patients

Ni Fan, MD PhD, Sravanthi Lavu, MBBS, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 5457.

https://doi.org/10.1182/blood-2018-99-112587

Published: 2018

Journal Articles

Extreme Thrombocytosis: Influence of Care Setting and Likelihood of Occult Malignancy

Ronan W. Hsieh, MD, Aishwarya Ravindran, MBBS, C. Christopher Hook, MD, Rajiv K. Pruthi, MBBS, Ariela L. Marshall, MD, Aneel A. Ashrani, MD, Kebede H. Begna, MD, Timothy G. Call, MD, William J. Hogan, MBBCh, Mark R. Litzow, MD, James D. Hoyer, MD, Jennifer L. Oliveira, MD, Prakash Vishnu, MD FACP, Ayalew Tefferi, MD, Michelle A. Elliott, MD, Aref Al-Kali, MD, Alexandra P. Wolanskyj-Spinner, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 1644.

https://doi.org/10.1182/blood.V130.Suppl_1.1644.1644

Published: 2017

Journal Articles

Characteristics and Outcome of Direct Antiglobulin Test-Negative Hemolytic Anemia: A Case Series

Aishwarya Ravindran, MBBS, Janani Sankaran, MBBS, Min Shi, MD PhD, Eapen K. Jacob, MD, Justin D. Kreuter, MD, Jeffrey L. Winters, MD, C. Christopher Hook, MD, Timothy G. Call, MD, Ariela L. Marshall, MD, Rajiv K. Pruthi, MD, Aneel A. Ashrani, MD MS, Kebede H. Begna, MD, Neil E. Kay, MD, Ronald S. Go, MD

Blood (2016) 128 (22): 2451.

https://doi.org/10.1182/blood.V128.22.2451.2451

Published: 2016

Journal Articles

Real-Life Incidence of Cancer Following a First Unprovoked Venous Thrombosis: Results from the Epigetbo Study

Aurelien Delluc, MD PhD, Karine Lacut, Jean Christophe Ianotto, Cecile Tromeur, MD, Francis Couturaud, MD PhD, Gregoire Le Gal, MDPhD, Dominique Mottier, PhD MD

Blood (2016) 128 (22): 415.

https://doi.org/10.1182/blood.V128.22.415.415

Published: 2016

Journal Articles

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism

Ryma Ihaddadene, Daniel J. Corsi, Alejandro Lazo-Langner, Sudeep Shivakumar, Ryan Zarychanski, Vicky Tagalakis, Susan Solymoss, Nathalie Routhier, James Douketis, Gregoire Le Gal, Marc Carrier

Blood (2016) 127 (16): 2035–2037.

https://doi.org/10.1182/blood-2015-11-682963

Published: 2016

Journal Articles

High Incidence of Secondary Malignancies after Reduced Intensity Allo-SCT: Results of a Single-Center Study with Extended Follow-up

Jeremy Delage, Stephane Vigouroux, Reza Tabrizi, Catherine Mohr, Pascal Turlure, MD, Noel Milpied

Blood (2015) 126 (23): 4353.

https://doi.org/10.1182/blood.V126.23.4353.4353

Published: 2015

Journal Articles

Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism

Ryma Ihaddadene, BHSc, MSc, Daniel J Corsi, PhD, Alejandro Lazo-Langner, MD, Sudeep Shivakumar, MD, Vicky Tagalakis, MD MSc, Ryan Zarychanski, MD MSc, Susan Solymoss, MD, Nathalie Routhier, MD, James D. Douketis, MD, Marc Carrier, MD MSc

Blood (2015) 126 (23): 625.

https://doi.org/10.1182/blood.V126.23.625.625

Published: 2015

Journal Articles

Screening for Occult Malignancy Following First Unprovoked VTE: A Single Centre Experience

Ruochen Li, BA (Hons), MB BChir, Cara Doyle, BN (Hons) RGN, Lara N Roberts, MD, Kathryn Jane Lang, MRCP, MBBS, Emma Gee, Julia Czuprynska, MBBS, Raj K Patel, MD, Roopen Arya, PhD

Blood (2015) 126 (23): 3550.

https://doi.org/10.1182/blood.V126.23.3550.3550

Published: 2015

Journal Articles

Secondary Hemophagocytic Lymphohistiocytosis As a Presentation For Peripheral T-Cell Lymphoma

Mahender Yellu, M.D., Stephen Medlin, DO, FACP

Blood (2013) 122 (21): 5068.

https://doi.org/10.1182/blood.V122.21.5068.5068

Published: 2013

Journal Articles

The Risk of Malignancy Following Idiopathic Venous Thromboembolism: A Population-Based Cohort Study

Dimple Kondal, PhD, Susan R. Kahn, MD, MSc, Vicky Tagalakis, MD, MSc

Blood (2011) 118 (21): 5255.

https://doi.org/10.1182/blood.V118.21.5255.5255

Published: 2011

Journal Articles

Incidence and Clinical Outcomes of Occult Malignancies Detected by Computed Tomographic Pulmonary Angiography in Patients with Acute Pulmonary Embolism.

Yi-Hao Shen, Phil Wells, Carole Dennie, MD, MSc, Marc Carrier, MD, MSc

Blood (2009) 114 (22): 2983.

https://doi.org/10.1182/blood.V114.22.2983.2983

Published: 2009

Journal Articles

Malignancies Occurring during Therapy with Tyrosine Kinase Inhibitors (TKI) for Chronic Myeloid Leukemia (CML) and Other Hematologic Malignancies.

Dushyant Verma, MD, FACP, Hagop M. Kantarjian, MD, Mary Beth Rios, Susan O’Brien, MD, Pat Ault, Elizabeth M. Burton, Zeev Estrov, MD, Gautam Borthakur, MD, Srdan Verstovsek, MD, PhD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Jorge Cortes, MD

Blood (2008) 112 (11): 2125.

https://doi.org/10.1182/blood.V112.11.2125.2125

Published: 2008

Journal Articles

Extreme Leukocytosis in the 21st Century Is Often Iatrogenic

Zachary P. Hugo, MD, Michael C. Perry, MD, David P. Steensma, MD, FACP

Blood (2008) 112 (11): 5401.

https://doi.org/10.1182/blood.V112.11.5401.5401

Published: 2008

Journal Articles

Chronic B-Cell Dyscrasias Are an Important Clinical Feature of LGL Leukemia.

Aaron D. Viny, BS, Alan Lichtin, M.D., Brad Pohlman, M.D., Zachary Nearman, B.S., Thomas Loughran, Jr., M.D., Jaroslaw P. Maciejewski, M.D./Ph.D

Blood (2007) 110 (11): 4675.

https://doi.org/10.1182/blood.V110.11.4675.4675

Published: 2007

Journal Articles

An Unusual Form of Immune Thrombocytopenic Purpura Characertized by a Platelet Activating IgG Antibody.

Soames Boyle, Tamas Alexy, MD, PhD, Leanne Rhochanda, Howard A. Liebman, MD

Blood (2006) 108 (11): 1086.

https://doi.org/10.1182/blood.V108.11.1086.1086

Published: 2006

Journal Articles

Incidental Finding of Malignancy by CT Angiogram of Chest in Patients Highly Suspected for Pulmonary Embolism.

Aref Agheli, MD, LMCC, Seema Naik, MD, Alka Arora, MD, Yelena Yadgarova, MD, Ashish Sangal, MD, Maged Khalil, MD, Zili He, MD, Elliot Bondi, MD, William Steier, MD, Madhumati Kalavar, MD

Blood (2006) 108 (11): 4089.

https://doi.org/10.1182/blood.V108.11.4089.4089

Published: 2006

Journal Articles

A Pilot Application of SELDI Mass Spectrometry To Study Proteomic Patterns in Plasma from Patients with T-Cell Large Granular Lymphocyte Leukemia.

Magdalena Plasilova, M.D., Ph.D., Robert Christner, Ph.D., Ronghzi Wu, Ph.D., Jaroslaw P. Maciejewski, M.D., Ph.D.

Blood (2004) 104 (11): 3869.

https://doi.org/10.1182/blood.V104.11.3869.3869

Published: 2004

Journal Articles

The Incidence and Timing of Unprovoked Venous Thromboembolism Prior to the Diagnosis of Common Cancers.

Richard White, MD, Ted Wun, MD, Arti Parikh-Patel, Danielle Harvey, PhD, Helen Chew, PhD

Blood (2004) 104 (11): 2582.

https://doi.org/10.1182/blood.V104.11.2582.2582

Published: 2004

NARROW

Megakaryocyte Reprogramming in Breast Cancer

Extramedullary Hematopoiesis in the Absence of Myeloproliferative Neoplasm: Mayo Clinic Case Series of 309 Patients

Extreme Thrombocytosis: Influence of Care Setting and Likelihood of Occult Malignancy

Characteristics and Outcome of Direct Antiglobulin Test-Negative Hemolytic Anemia: A Case Series

Real-Life Incidence of Cancer Following a First Unprovoked Venous Thrombosis: Results from the Epigetbo Study

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism

High Incidence of Secondary Malignancies after Reduced Intensity Allo-SCT: Results of a Single-Center Study with Extended Follow-up

Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism

Screening for Occult Malignancy Following First Unprovoked VTE: A Single Centre Experience

Secondary Hemophagocytic Lymphohistiocytosis As a Presentation For Peripheral T-Cell Lymphoma

The Risk of Malignancy Following Idiopathic Venous Thromboembolism: A Population-Based Cohort Study

Incidence and Clinical Outcomes of Occult Malignancies Detected by Computed Tomographic Pulmonary Angiography in Patients with Acute Pulmonary Embolism.

Malignancies Occurring during Therapy with Tyrosine Kinase Inhibitors (TKI) for Chronic Myeloid Leukemia (CML) and Other Hematologic Malignancies.

Extreme Leukocytosis in the 21st Century Is Often Iatrogenic

Chronic B-Cell Dyscrasias Are an Important Clinical Feature of LGL Leukemia.

An Unusual Form of Immune Thrombocytopenic Purpura Characertized by a Platelet Activating IgG Antibody.

Incidental Finding of Malignancy by CT Angiogram of Chest in Patients Highly Suspected for Pulmonary Embolism.

A Pilot Application of SELDI Mass Spectrometry To Study Proteomic Patterns in Plasma from Patients with T-Cell Large Granular Lymphocyte Leukemia.

The Incidence and Timing of Unprovoked Venous Thromboembolism Prior to the Diagnosis of Common Cancers.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only